Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Glaukos Corp (GKOS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6413
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such as microstent devices to treat glaucoma such as iStent trabecular micro-bypass stent for the treatment of mild- tomoderate open-angle glaucoma. Glaukos’ iStent is used in conjunction with cataract surgery. Glauko’s iStent improves outflow by creating a patent bypass between the anterior chamber and Schlemm’s canal. The company markets its products through a network of distributors in Germany, Italy, Canada, Portugal, Spain, the UK and France, among others. Glaukos is headquartered in San Clemente, California, the US.

Glaukos Corp (GKOS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Glaukos Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Glaukos Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Glaukos Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Glaukos Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Glaukos Acquires IOP Sensor System from DOSE Medical 10
Venture Financing 11
Glaukos Raises US$30 Million In Series F Financing 11
Glaukos Raises US$6 Million In Venture Financing 13
Glaukos Raises US$4.5 Million In Venture Financing 14
Partnerships 15
Glaukos Enters into Development Agreement with D. Western Therapeutics Institute 15
Equity Offering 16
Glaukos Raises USD124.2 Million in IPO 16
Glaukos Corp – Key Competitors 18
Glaukos Corp – Key Employees 19
Glaukos Corp – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 02, 2018: Glaukos reports second quarter 2018 financial results 21
May 09, 2018: Glaukos Announces First Quarter 2018 Financial Results 22
Feb 28, 2018: Glaukos Reports Fourth Quarter and Full Year 2017 Financial Results 23
Nov 07, 2017: Glaukos Announces Third Quarter 2017 Financial Results 24
Aug 02, 2017: Glaukos Announces Second Quarter 2017 Financial Results 25
May 03, 2017: Glaukos Announces First Quarter 2017 Financial Results 26
Mar 01, 2017: Glaukos Announces Fourth Quarter & Full Year 2016 Financial Results 27
Corporate Communications 28
Feb 22, 2017: Preeminent Ophthalmologist, L. Jay Katz Joins Glaukos as Chief Medical Officer 28
Feb 06, 2017: Joseph Gilliam to Join Glaukos Corporation as Chief Financial Officer and Senior Vice President of Corporate Development 29
Feb 01, 2017: Glaukos Promotes Chris M. Calcaterra to Chief Operating Officer 30
Product News 31
Feb 27, 2018: Glaukos Technologies Featured in Numerous Presentations at 2018 American Glaucoma Society Meeting 31
Sep 14, 2017: Glaukos to Outline Growth Strategy at Investor Day 33
May 01, 2017: Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Glaukos Corp, Medical Equipment, Key Facts, 2017 2
Glaukos Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Glaukos Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Glaukos Corp, Deals By Market, 2012 to YTD 2018 8
Glaukos Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Glaukos Acquires IOP Sensor System from DOSE Medical 10
Glaukos Raises US$30 Million In Series F Financing 11
Glaukos Raises US$6 Million In Venture Financing 13
Glaukos Raises US$4.5 Million In Venture Financing 14
Glaukos Enters into Development Agreement with D. Western Therapeutics Institute 15
Glaukos Raises USD124.2 Million in IPO 16
Glaukos Corp, Key Competitors 18
Glaukos Corp, Key Employees 19
Glaukos Corp, Subsidiaries 20

List of Figures
Glaukos Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Glaukos Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Glaukos Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vocalink Limited:企業の戦略・SWOT・財務分析
    Vocalink Limited - Strategy, SWOT and Corporate Finance Report Summary Vocalink Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Banco Popular Espanol, S.A.:戦略・SWOT・企業財務分析
    Banco Popular Espanol, S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco Popular Espanol, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bharat Heavy Electricals Ltd (BHEL):企業の財務・戦略的SWOT分析
    Bharat Heavy Electricals Ltd (BHEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bet Shemesh Engines Holdings (1997) Ltd:企業の戦略・SWOT・財務分析
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Volkswind GmbH-エネルギー分野:企業M&A・提携分析
    Summary Volkswind GmbH (Volkswind), a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon …
  • Systex Corp (6214):企業の財務・戦略的SWOT分析
    Systex Corp (6214) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Matsuda Sangyo Co Ltd (7456):企業の財務・戦略的SWOT分析
    Matsuda Sangyo Co Ltd (7456) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Simply Energy:企業の戦略的SWOT分析
    Simply Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • FDC Ltd (FDC):企業の財務・戦略的SWOT分析
    Summary FDC Ltd (FDC) is a pharmaceutical company that manufactures and markets of oral rehydration salts, ophthalmics and functional foods. The company also provides active pharmaceuticals ingredients (APIs). It provides products for the therapeutic segments of anti-infectives, gastrointestinals, o …
  • Strike Energy Ltd (STX):企業の財務・戦略的SWOT分析
    Summary Strike Energy Ltd (Strike Energy) is an oil and gas exploration and development company that explores, produces, and develops shale oil and gas. The company provides properties such as Eagle Ford Shale, Permian Basin, Cooper Basin, gulf coast conventional, and others. It has exploration and …
  • Valneva SE (VLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Valneva SE (Valneva) is a biotech company that develops lifesaving vaccines. The company’s products include IXIARO, a vaccine indicated for the prevention of Japanese encephalitis; and Dukoral, a vaccine indicated for the prevention of cholera and diarrhea; clostridium difficile, lyme, chiku …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • Bureau Veritas SA (BVI):電力:M&Aディール及び事業提携情報
    Summary Bureau Veritas SA (Bureau Veritas) is a provider of testing, inspection and certification services. The company offers asset management, certification, consulting, inspection and audits, testing and analysis, and training. It serves aeronautics, agriculture, automotive, construction and real …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • Avebe U.A.:企業の戦略的SWOT分析
    Avebe U.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • ARISCOM Compagnia di Assicurazioni S.p.A.:企業の戦略・SWOT・財務情報
    ARISCOM Compagnia di Assicurazioni S.p.A. - Strategy, SWOT and Corporate Finance Report Summary ARISCOM Compagnia di Assicurazioni S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Pint Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a developer, manufacturer and marketer of originator drugs in rare disease, oncology and specialty conditions. The company offers its products in the form of tablets, injections, small compounds, drugs, implants …
  • TPI Composites Inc (TPIC):企業の財務・戦略的SWOT分析
    TPI Composites Inc (TPIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆